| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 18559788 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 102 journal articles in the PubMed database | Email to a friend | | |
| Stichenwirth M, Riedl E, Pehamberger H, et al.
Pyoderma gangrenosum in a patient with seronegative rheumatoid arthritis during therapy with adalimumab: toxic effects of adalimumab or failure of adalimumab to prevent the onset of this phenomenon? [Case Reports, Letter]
Arch Dermatol 2008 Jun; 144(6):817-8.
Full Citation | Publisher Full Text | Find Related Articles | | Vandevyvere K, Luyten FP, Verschueren P, et al.
Pyoderma gangrenosum developing during therapy with TNF-alpha antagonists in a patient with rheumatoid arthritis. [JOURNAL ARTICLE]
Clin Rheumatol 2007 Sep 18.
Full Citation | | Furst DE, Schiff MH, Fleischmann RM, et al.
Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis). [Clinical Trial, Journal Article, Randomized Controlled Trial]
J Rheumatol 2003 Dec; 30(12):2563-71.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Weinblatt ME, Keystone EC, Furst DE, et al.
Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial. [Clinical Trial, Journal Article, Randomized Controlled Trial]
Arthritis Rheum 2003 Jan; 48(1):35-45.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Adalimumab: new preparation. Rheumatoid arthritis: no therapeutic advance. [Journal Article]
Prescrire Int 2004 Oct; 13(73):171-5.
Abstract | Full Citation | Find Related Articles | | Martín J, Ricart J, Alcácer J, et al.
Adalimumab-induced lupus erythematosus. [Journal Article]
Lupus 2008; 17(7):676-8.
Abstract | Full Citation | Find Related Articles | | Liozon E, Ouattara B, Loustaud-Ratti V, et al.
Severe polymyositis and flare in autoimmunity following treatment with adalimumab in a patient with overlapping features of polyarthritis and scleroderma. [Letter]
Scand J Rheumatol 2007 Nov-Dec; 36(6):484-6.
Full Citation | Find Related Articles | | Keystone EC, Kavanaugh AF, Sharp JT, et al.
Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-controlled, 52-week trial. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
Arthritis Rheum 2004 May; 50(5):1400-11.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | van Rijthoven AW, Bijlsma JW, Canninga-van Dijk M, et al.
Onset of systemic lupus erythematosus after conversion of infliximab to adalimumab treatment in rheumatoid arthritis with a pre-existing anti-dsDNA antibody level. [JOURNAL ARTICLE]
Rheumatology (Oxford) 2006 Jul 31.
Full Citation | Publisher Full Text | Find Related Articles |   |
|
| |
Advertise on this site.
|
